Ioannis P. Trougakos

Author

National and Kapodistrian University of Athens ORCID

Also Known As

Fiona L.L. Stratford, Fokialakis, Nikolas, I P Trougakos, I Trougakos, I. P. Trougakos, I. Trougakos, I.P Trougakos, I.P. Trougakos, IOANNIS P. TROUGAKOS, Ioannis P TROUGAKOS

309

Publications

15.2K

Citations

H-Index

167

Concepts

All Affiliations

National and Kapodistrian University of Athens National Hellenic Research Foundation Alexandra Hospital Academy of Athens University of Patras

About

Ioannis P. Trougakos is an author at National and Kapodistrian University of Athens specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	48	2.2K
2	Natural Sciences	10	10	526
3	Health Sciences	3	3	224
4	Engineering	2	2	64
5	Public Health	1	1	17

Ioannis P. Trougakos

118

Publications

11.3K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky, Kotb Abdelmohsen, Akihisa Abe, Autophagy	2016	5.9K
Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. Niki Chondrogianni, Fiona L. L. Stratford, Ioannis P. Trougakos, PubMed	2003	328
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients Cristina Bergamaschi, Evangelos Terpos, Margherita Rosati, Cell Reports	2021	223
Silencing Expression of the Clusterin/Apolipoprotein J Gene in Human Cancer Cells Using Small Interfering RNA Induces Spontaneous Apoptosis, Reduced Growth Ability, and Cell Sensitization to Genotoxic and Oxidative Stress Ioannis P. Trougakos, Alan So, Burkhard Jansen, Cancer Research ApoptosisCell DeathClusterin/apolipoprotein JCancer BiologyTumor Biology	2004	204
Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction Ioannis P. Trougakos, Maria V. Poulakou, M. Stathatos, Experimental Gerontology Metabolic SyndromeAgingCardiovascular DiseaseLongevityMyocardial Infarction	2002	164
Age‐dependent and gender‐dependent antibody responses against <scp>SARS‐CoV</scp>‐2 in health workers and octogenarians after vaccination with the <scp>BNT162b2 mRNA</scp> vaccine Evangelos Terpos, Ioannis P. Trougakos, Filia Apostolakou, American Journal of Hematology VaccinationVaccine SafetyVaccinologyHealth WorkersVaccine Development	2021	156
Intracellular Clusterin Inhibits Mitochondrial Apoptosis by Suppressing p53-Activating Stress Signals and Stabilizing the Cytosolic Ku70-Bax Protein Complex Ioannis P. Trougakos, Magda Lourda, Marianna H. Antonelou, Clinical Cancer Research	2008	152
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose Evangelos Terpos, Ioannis P. Trougakos, Maria Gavriatopoulou, Blood	2021	144
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Blood Cancer Journal	2021	126
Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin Panagiotis Efentakis, Georgios Kremastiotis, Aimilia Varela, Blood	2018	113

Page 1